ArticleAsian Pacific journal of cancer prevention : APJCP2025
Mixed Methods Study of Care Pathway and Delay in Obtaining Health Services by Breast Cancer Patients in India.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Barriers to help-seeking for cancer in India: A scoping review.The Indian journal of medical research · 2026Article
- Pathways to Care, Out- of- Pocket Expenditure, and Associated Factors Among Breast Cancer Patients in Kerala, India: A Hospital-Based Cross- Sectional Study.Asian Pacific journal of cancer prevention : APJCP · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Delay in receiving treatment or untimely discontinuation can impact patient survival. This study addresses the literature gap in knowledge about care pathway of patients following initiation of treatment, quantifies the delays in obtaining healthcare services and explores the challenges faced by them in this process.
methodsA concurrent triangulation mixed method study was conducted. All breast cancer patients above 18 years, who were aware of their diagnosis and whose treatment had commenced were included with their consent. The final sample size was 150. Patient pathway was documented through in-depth interviews and delay in access, diagnosis, and various treatment modalities was quantified after reviewing patient records. Factors associated with overall delay (from onset of symptoms to initiation of treatment) were identified by bivariate analysis. Inductive thematic analysis of interviews was done to identify reasons for delay.
resultsOf 150 patients, 111 (74%) consulted at least two healthcare facilities and 75 (50%) consulted only government facilities during their treatment. Majority, 124 (82.6%) patients faced delay in their care pathway; 88 (58.6%) experienced overall delay (median duration 109 days) which was significantly associated with patient's education and caregiver's occupation (p<0.05), and 48 (32%) out of 149 women were delayed in initiation of chemotherapy. Median access, diagnostic and treatment interval were 60 days, 20 days, and 6 days respectively. Median duration between surgery and chemotherapy, and surgery and radiotherapy was 10 days and 139 days respectively. The major themes that emerged in access delay were neglect, avoidance, and reliance on family. Diagnostic delay included themes of misdiagnosis and difficulty in navigating healthcare systems. Treatment delay included themes of misconceptions, avoidance, neglect, and affordability and accessibility of services.
conclusionMajority of the patients visited at least two facilities and experienced delay in receiving healthcare services. Both patient and provider side challenges were responsible for delay.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.